Taniguchi, Hiroya http://orcid.org/0000-0002-0567-363X
Masuishi, Toshiki
Kawazoe, Akihito
Muro, Kei
Kadowaki, Shigenori
Bando, Hideaki
Iino, Shuichi
Kageyama, Rie
Yoshino, Takayuki
Funding for this research was provided by:
Dainippon Sumitomo Pharma
Article History
Received: 7 January 2021
Accepted: 4 July 2021
First Online: 21 July 2021
Declarations
:
: Authors have the following conflicts of interest to disclose: Hiroya Taniguchi reports grants from Daiichi Sankyo, Isofol, MSD, Novartis, Ono, Pfizer, Sumitomo Dainippon Pharma, Sysmex, and Takeda; and personal fees from Bayer, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eli Lilly, MBL, Merck Bio Pharma, Mitsubishi Tanabe Pharma, MSD, Nippon Kayaku, Novartis, Sanofi, Taiho, Takeda, and Yakult Honsha. Toshiki Masuishi reports research funding from Daiichi Sankyo, MSD, and Ono; and honoraria from Bayer, Chugai, Lilly Japan, Merck Serono, Sanofi, Taiho, Takeda, and Yakult Honsha. Akihito Kawazoe reports research funding from MSD, Ono, Sumitomo Dainippon, and Taiho. Kei Muro reports research funding from Daiichi Sankyo, Mediscience Planning, MSD, Parexel International, Pfizer, Sanofi, Solasia Pharma, and Sumitomo Dainippon Pharma; and personal fees from Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly, Ono Pharmaceutical Co., Ltd., Sanofi, and Takeda Pharmaceutical. Shigenori Kadowaki reports grants from Chugai, Eli Lilly, MSD, Nobelpharma, Ono, and Taiho; and personal fees from Bayer, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Merck, Ono, Taiho, and Yakult Honsha. Hideaki Bando reports research funding from AstraZeneca and Sysmex; and honoraria for lecturing from Chugai Pharma, Eli Lilly Japan, Sanofi, Taiho Pharmaceutical, Takeda, and Yakult Honsha. Shuichi Iino and Rie Kageyama are employees of Sumitomo Dainippon Pharma Co., Ltd. Takayuki Yoshino reports research funding from Taiho Pharmaceutical, Sumitomo Dainippon Pharma, Ono Pharmaceutical, Chugai Pharmaceutical, Amgen, PAREXEL International, MSD, Daiichi Sankyo, and Sanofi.
: Study methodologies conformed to the standards set by the Declaration of Helsinki and were approved by the appropriate ethics committee at each study site. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at each study site and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. All data were anonymized, and no identifying information is included in this article.